PARPi and Ovarian Cancer Survival

Clinical trial NCT06838429 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06838429
Sponsor: Shanghai Gynecologic Oncology Group
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Epithelial Ovarian Cancer, Fallopian Tube or Peritoneum PARP Inhibitor

Start date: 2025-03-01
Primary completion: 2026-03-01
Enrollment: 6000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.